DIAKRON PHARMACEUTICALS INC has a total of 24 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ALLERGAN HOLDINGS UNLIMITED COMPANY, SYNAPTEC DEV LLC and SIDEM PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 4 | |
#5 | Canada | 3 | |
#6 | Republic of Korea | 2 | |
#7 | China | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Organic chemistry methods | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rao Srirama | 8 |
#2 | Suryakumar Jayanthi | 6 |
#3 | Ramakrishnan Sankar | 6 |
#4 | Allard Stephane | 6 |
#5 | Sampathkumar Upparapalli | 6 |
#6 | Sahu Nilam | 6 |
#7 | Rao Javvaji Karunakara | 5 |
#8 | Bibbs Jeffrey A | 5 |
#9 | Reddy Reguri Buchi | 5 |
#10 | Venkatesan Elumalai | 5 |
Publication | Filing date | Title |
---|---|---|
KR20140090663A | An extended release formulation of a direct thrombin inhibitor | |
MX2012005165A | Process for the preparation of pyrazinone thrombin inhibitor and its intermediates. | |
US7815946B1 | Anti-diabetic and cholesterol lowering preparation from fenugreek seeds | |
WO2004075893A1 | Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin ii receptor blocker | |
AU2003270562A1 | Calcium channel blockers | |
US7338941B2 | Pharmaceutical compositions for lowering blood glucose and blood cholesterol levels |